TherapeuticsMD Turns To Profit In Q2 - Quick Facts

TherapeuticsMD, Inc. (TXMD), a women's healthcare company, reported Monday that its second-quarter net income was $112.28 million or $12.39 per share, compared to net loss of $42.65 million or $5.41 per share a year ago.

Total net revenue grew to $28.56 million from last year's $23.00 million.

Hugh O'Dowd, CEO of TherapeuticsMD, said, ""We saw solid revenue growth during the quarter, with an increase of 24% over the prior year period, while also experiencing a 21% decrease in operating expenses. The U.S. Food and Drug Administration's recent approval of our supplemental new drug application for ANNOVERA has significantly enhanced our ability to meet demand for the product."

The company said it recently repaid $120 million dollars of debt with the proceeds of divestiture of vitaCare unit.

In pre-market activity on Nasdaq, TherapeuticsMD shares were trading at $9.97, up 8.25 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Netflix, Inc. said it is adding a new feature to offer a more personalized mobile games experience on the platform. In a statement, Sophia Yang, Product Manager, Mobile Games, said the company is rolling out the ability to create game handles, with which members will be able to create a unique public username. This can be used across all Netflix games. General Motors Co. has delayed its plan to require employees to return to office many days a week until next year, reports said citing an internal memo signed by CEO Mary Barra. Last week, the company had announced that corporate workers would be required to return to respective offices at least three days a week, beginning later this year, as the COVID-19 pandemic eases. Ford Motor Co. is seeking a new trial in a Georgia court after a jury reached a $1.7 billion verdict in a lawsuit against the automotive major regarding a truck rollover accident, The Wall Street Journal reported. In the new court filings, Ford said it was unfairly precluded from providing evidence and thus defending against claims that its trucks were defective.
Follow RTT